Jasper van der Lugt
- Virology top 5%
- HIV Research and Treatment 12
- Genetics top 5%
- Glioma Diagnosis and Treatment 22
- Virus-based gene therapy research 4
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 15
- HIV/AIDS Research and Interventions 6
- Emergency Medicine top 5%
- HIV-related health complications and treatments 8
- Health Informatics top 10%
-
- Neuroblastoma Research and Treatments 13
-
- CAR-T cell therapy research 5
- Co-authors
- Kiat RuxrungthamDavid M. BurgerWill SawyerMarta BoffitoAnchalee AvihingsanonAndrew HillStephen J. KerrJintanat Ananworanich
- Cited by
- VirologyGeneticsInfectious Diseases
- Journals
- Nature (1 paper)New England Journal of Medicine (1 paper)Journal of Clinical Oncology (8 papers)
- Partner nations
- NetherlandsUnited StatesAustralia
In The Last Decade
Jasper van der Lugt
54 papers receiving 789 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Virology 138
- Genetics 193
- Infectious Diseases 277
- Emergency Medicine 118
- Health Informatics 14
Countries citing papers authored by Jasper van der Lugt
This map shows the geographic impact of Jasper van der Lugt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasper van der Lugt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasper van der Lugt more than expected).
Fields of papers citing papers by Jasper van der Lugt
This network shows the impact of papers produced by Jasper van der Lugt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasper van der Lugt. The network helps show where Jasper van der Lugt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jasper van der Lugt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 19 | |
| 8 | 2023 | 1 | |
| 9 | Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutationsbreakdown → | 2023 | 125 |
| 10 | Ultra-fast deep-learned CNS tumour classification during surgerybreakdown → | 2023 | 96 |
| 11 | 2023 | 1 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 0 | |
| 14 | 2023 | 1 | |
| 15 | 2011 | 51 | |
| 16 | 2011 | 20 | |
| 17 | 2009 | 7 | |
| 18 | 2009 | 19 | |
| 19 | 2008 | 24 | |
| 20 | 2008 | 29 |
About Jasper van der Lugt
Jasper van der Lugt is a scholar working on Virology, Genetics and Infectious Diseases, having authored 59 papers that have together received 808 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (22 papers), HIV/AIDS drug development and treatment (15 papers), Neuroblastoma Research and Treatments (13 papers), HIV Research and Treatment (12 papers), HIV-related health complications and treatments (8 papers), HIV/AIDS Research and Interventions (6 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Virology (138 citations), Genetics (193 citations) and Infectious Diseases (277 citations). Jasper van der Lugt has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Kiat Ruxrungtham, David M. Burger, Will Sawyer, Marta Boffito, Anchalee Avihingsanon, Andrew Hill, Stephen J. Kerr, Jintanat Ananworanich, Praphan Phanuphak and Pieter Wesseling. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.